Understanding Alpha-1 Liver Disease (AATD-LD) can be a complex journey, but with the right information and support, it's a journey you won't have to make alone.
Go to the WeConnect Home Page.
What are clinical trials for Alpha-1 Liver Disease?
Clinical studies (or clinical trials) are research studies where people with Alpha-1 Liver Disease volunteer to help find answers to specific health questions.
Explore investigational treatments for Alpha-1 Liver Disease:
Clinical studies are the safest and fastest way to find and help develop innovative treatments and ways to improve health.
Explore safety for people with Alpha-1 Liver Disease:
Clinical studies help us learn how to safely use treatments in populations where they haven’t been tested before, such as children.
Are there any Alpha-1 Liver Disease studies enrolling now?
Enrolling Now.
The Redwood Study
The Redwood Study may help researchers better understand Alpha-1 Antitrypsin Deficiency–Associated Liver Disease and learn more about an investigational study drug.
Why should I consider a clinical study for Alpha-1 Liver Disease?
Hope for better Alpha-1 Liver Disease health:
If standard treatments haven’t worked or if you’re unable to tolerate side effects, clinical studies may provide another option.
Contribute to Alpha-1 Liver Disease medical knowledge:
By participating, you contribute to advancing our understanding of diseases and treatments.
Promote health equity for Alpha-1 Liver Disease patients:
Diverse participation in clinical research helps to inform us how investigational drugs may work in diverse patient populations.
What about my eligibility and safety in an Alpha-1 Liver Disease clinical study?
Eligibility criteria for Alpha-1 Liver Disease clinical studies:
All clinical studies have guidelines about who can participate based on factors like age, sex, disease type, and medical history.
Strict rules for Alpha-1 Liver Disease clinical studies:
Researchers follow rules set by regulatory organizations in each country, such as the FDA, to ensure your safety during the clinical study.
Oversight and review of Alpha-1 Liver Disease clinical studies:
Institutional Review Boards in the US or Ethics Committees outside the US are an independent part of clinical study programs to help ensure the safety, protection, and privacy of participant in research trials.